The effect of sphingomyelin synthase 2 (SMS2) deficiency on the expression of drug transporters in mouse brain
- 1 August 2011
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 82 (3), 287-294
- https://doi.org/10.1016/j.bcp.2011.04.009
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Pujiang Program (2009ZX09301-011)
- National Drug Innovative Program
This publication has 29 references indexed in Scilit:
- Regulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrierTrends in Pharmacological Sciences, 2010
- Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P‐glycoprotein up‐regulation at the blood‐brain barrierThe FASEB Journal, 2008
- Hypoxia-induced changes in the expression of rat hepatobiliary transporter genesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- Tumor Necrosis Factor α and Endothelin-1 Increase P-Glycoprotein Expression and Transport Activity at the Blood-Brain BarrierPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2006
- Regulation of Multidrug Resistance by Pro-Inflammatory CytokinesCurrent Cancer Drug Targets, 2006
- Transporters and Drug Discovery: Why, When, and HowMolecular Pharmaceutics, 2006
- Impact of Drug Transporter Studies on Drug Discovery and DevelopmentPharmacological Reviews, 2003
- Cytokine Regulation of P-GlycoproteinDrug Metabolism Reviews, 2003
- The functional purification of P-glycoprotein is dependent on maintenance of a lipid–protein interfaceBiochimica et Biophysica Acta (BBA) - Biomembranes, 1997
- Sphingomyelin and derivatives as cellular signalsProgress in Lipid Research, 1991